You are here
Home > PRA Health Sciences

PRA Health Sciences selected by BARDA to be a member of its exclusive Clinical Studies Network

With the new contract, PRA will assist Biomedical Advanced Research and Development Authority (BARDA) in the development of medical countermeasures for public health RALEIGH, N.C., Oct. 06, 2020 (GLOBE NEWSWIRE) — PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today it has been selected by the Biomedical Advanced Research and Development Authority (BARDA) to be a […]

PRA Health Sciences Announces Appointment of New Director

RALEIGH, N.C., Sept. 15, 2020 (GLOBE NEWSWIRE) — PRA Health Sciences, Inc. (NASDAQ:PRAH) today announced the appointment of Glen Stettin, M.D. to the Board of Directors of the Company, effective September 14, 2020. “We are delighted that Glen will be joining our Board of Directors.  With his widespread involvement in the healthcare field as both […]

PRA Health Sciences ready to navigate RACE Act requirements for pediatric oncology

U.S. law requiring clinical research for pediatric oncology treatments goes into effect mid-August 2020 RALEIGH, N.C., June 18, 2020 (GLOBE NEWSWIRE) — Between 2007-2017, 78 novel adult cancer agents were approved by the U.S. Food and Drug Administration,1 but none of those drugs were researched to determine effectiveness for pediatric cancers. That is about to […]

PRA Enhances COVID-19 Monitoring Program with Integration of Microsoft Healthcare Bot Service

RALEIGH, N.C., June 12, 2020 (GLOBE NEWSWIRE) — PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today the enhancement of its commercial Health Harmony COVID-19 Monitoring Program with the integration of the Microsoft Healthcare Bot service. Users of PRA’s Health Harmony digital platform who enroll in their organization’s COVID-19 Monitoring Program can use the AI-based chatbot, which […]

Symphony Health to provide free access to new MetysTM COVID-19 Module for U.S. based life sciences industry during pandemic

Metys COVID-19 Module delivers pharmaceutical market analytics and intelligence quickly through a single access point RALEIGH, N.C., April 08, 2020 (GLOBE NEWSWIRE) — PRA Health Sciences (NASDAQ: PRAH) announced today that Symphony Health, a PRA Health Sciences company, will make a 30-day license of its newly released MetysTM COVID-19 Module available to the U.S. life […]

PRA Health Sciences Launches COVID-19 Monitoring Program

RALEIGH, N.C., March 20, 2020 (GLOBE NEWSWIRE) — PRA Health Sciences announced today the commercial availability of the COVID-19 Monitoring Program, a mobile app-driven, tiered initiative that allows employers, payers, providers and health systems to track the health and wellbeing of individuals who may be asymptomatic, exposed or diagnosed with COVID-19 during the pandemic. Based […]

Symphony Health Partners with Datavant for the Industry’s Deepest View of the Patient Journey

Life sciences customers will gain flexibility to build bespoke, fit-for-purpose data assets and strategies to support the development and delivery of life-enhancing drugs RALEIGH, N.C., March 11, 2020 (GLOBE NEWSWIRE) — PRA Health Sciences (NASDAQ: PRAH) announced today a partnership between Symphony Health and Datavant that expands the breadth of data available for integration and […]